UKHSA to stop publishing Covid modelling data in January
The R range and growth rate for England had been published weekly during the height of the pandemic, and fortnightly since April this year.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The UK Health Security Agency will stop publishing modelling data on coronavirus in early January.
Chief data scientist Dr Nick Watkins said the publication of this specific data is “no longer necessary” as the country is living with Covid thanks to vaccines and therapeutics.
The R range and growth rate for England had been published weekly during the height of the pandemic, and fortnightly since April this year.
It was first published in May 2020 for all of the UK, until April 2021 when it was published for England only.
The reproductive rate, the R rate, refers to the number of people an infected person will pass the virus onto.
The UKHSA Epidemiology Modelling Review Group (EMRG) said that, following a detailed review, the next publication of its consensus statement on Covid-19 on January 6 “will be the last”.
It said Covid-19 incidence data will continue to be accessible from the Office for National Statistics infection survey.
Dr Watkins, chairman of the EMRG, said: “During the pandemic, the R value and growth rate served as a useful and simple indicator to inform public health action and Government decisions.
“Now that vaccines and therapeutics have allowed us to move to a phase where we are living with Covid-19, with surveillance scaled down but still closely monitored through a number of different indicators, the publication of this specific data is no longer necessary.
“We continue to monitor Covid-19 activity in a similar way to how we monitor a number of other common illnesses and diseases.
“All data publications are kept under constant review and this modelling data can be reintroduced promptly if needed, for example, if a new variant of concern was to be identified.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.